To Download a copy of the presentation click here.
To Download a copy of the updated Q&A Responses click here.
Moderator:
Dana S. Wollins, DrPH, MGC
Senior Vice President, Strategy
IDSA
Topics
BP Update
Chris Beddard
VP, Microbiology, BD Life Sciences
VP, Global Platform Leader, Microbiology
Diagnostic Solutions
CDC Blood Culture Quality Tools
Jake D. Bunn, MBA, MLS (ASCP)CM, LSSBB
Clinical Laboratory Scientist
Division of Laboratory Systems
U.S. Centers for Disease Control and Prevention
Blood Culture Utilization
Valeria Fabre, MD
Associate Professor of Medicine, Division of Infectious Diseases
Associate Medical Director, Antimicrobial Stewardship Program
Associate Hospital Epidemiologist
The Johns Hopkins Hospital
Aaron M. Milstone, MD, MHS
Professor of Pediatric Infectious Diseases and Epidemiology
Johns Hopkins Medicine
Sarah Turbett, MD
Associate Director, Clinical Microbiology Laboratories
Assistant Professor of Pathology and Medicine
Massachusetts General Hospital
Harvard Medical School
Romney M. Humphries, PhD, D(ABMM), M(ASCP), FIDSA
Director, The Division of Laboratory Medicine
Professor of Pathology, Microbiology, and Immunology
Medical Director of the Microbiology Laboratory
Vanderbilt University Medical Center
Q&A and Discussion - All speakers plus:
Carl Newman, Deputy Director, Office of Supply Chain Resilience, U.S. Food and Drug Administration
Ryan Lupert, JD, Regulatory Counsel, Acting Deputy Office Director for Patient Safety and Product Quality
U.S. Food and Drug Administration
